Trastuzumab Deruxtecan Improves Progression-Free Survival and Intracranial Response in Patients with HER2-Positive Metastatic Breast Cancer and Brain Metastases
Author:
- Anne JacobsonAJAnne Jacobson
Open Access
- 28 March 2022
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 27 (Supplement) , S3-S4